Boeing Back in the Sky: FAA Approval and Jet Orders Lift BA Stock – What Analysts Say

Boeing Back in the Sky: FAA Approval and Jet Orders Lift BA Stock – What Analysts Say

  • Stock price: About $213 per share as of the Oct. 17 close [1]. Boeing (BA) has traded roughly flat in recent sessions (near $210–$215). Over the past 12 months the shares have climbed roughly +45% [2], far outperforming the broader market.
  • Orders & backlog: Boeing’s backlog is enormous (~$619 billion, ~5,900 aircraft [3]). Recent deals have been huge – for example, a late-September order for 75 Boeing 787 Dreamliners by Turkish Airlines (plus 150 additional 737 MAX options) [4], and up to 22 Dreamliners to Uzbekistan Airways (∼$8.5B) [5]. Boeing is also reportedly in talks to sell “as many as 500” jets to China [6]. These mega-orders have propped up Boeing’s outlook. Deliveries are ramping up (385 jets delivered by Aug. 2025 vs. 348 in all of 2024 [7]).
  • Production & regulation: In mid-October the FAA raised Boeing’s 737 MAX production cap to 42 per month (from 38) [8], a key milestone enabling higher deliveries. Boeing’s CEO Kelly Ortberg notes the company won’t boost output until work on existing jets is finished – there’s still “a mountain of work” to certify its newest planes and even a “minor schedule delay” on the 777X can have a “pretty big financial impact” [9]. Boeing also faces regulatory scrutiny: an FAA probe into production issues is ongoing, and smaller MAX models (7 and 10) remain delayed [10]. In late Sep. the FAA partially restored Boeing’s own authority to self-certify 737/787 aircraft [11] (alternating weeks of FAA vs. Boeing reviews), which sent shares up ~5% on that news [12].
  • Financial health: Boeing’s recent results show steady improvement. In Q2 2025, revenue surged ~35% year-on-year (to ~$22.8B) and the GAAP loss narrowed sharply (about $612M vs. $1.44B year-ago) [13]. Free cash flow roughly breakeven marked progress after heavy burns in prior years. However, Boeing still carries large debt (~$53.3B debt vs ~$23B cash [14]) and has not yet restored its dividend. Analysts highlight cash flow and debt reduction as key priorities.
  • Analyst outlook: Wall Street is cautiously bullish. The consensus rating is roughly Moderate/Strong Buy [15], with an average 12-month target around the low $230s. Price targets range widely (~$140 on the low end up to $280+) [16], reflecting uncertainty. For instance, Bank of America reiterated a Buy with a $270 target [17], and Bernstein’s Douglas Harned recently maintained an Outperform rating and a $287 target [18]. Harned noted that Boeing has essentially completed a key production “rework” phase for the MAX, meaning one important bottleneck is cleared [19]. Conversely, bearish voices warn that fresh delays or safety setbacks could hurt BA sharply (some analysts say a drop toward the ~$120 range is possible in a worst-case turnaround failure [20]).
  • Industry context: Boeing is a Dow 30 stock and sits at the heart of a booming aerospace & defense sector. The S&P Aerospace & Defense index is up about +44% YTD [21], driven by strong global travel demand and record defense budgets. The U.S. defense budget for 2025 is roughly $849 billion (with an additional ~$156 B in supplemental funding from a new budget act) [22]. That spending directly benefits major contractors like Boeing. Boeing competes with Airbus in commercial aviation – Airbus’s A320neo family has now surpassed Boeing’s 737 as the top-selling narrowbody [23] – and by August 2025 Airbus had delivered 434 jets vs. Boeing’s 385 [24]. In defense, Boeing is vying (alongside Northrop Grumman) for the U.S. Navy’s next-generation F/A-XX fighter [25]. TD Cowen analyst Roman Schweizer observes that selecting Boeing for that program would be “an important decision to keep pace” with China’s advanced fighter development [26]. All told, experts say Boeing’s stock is riding these industry tailwinds – but it must execute carefully.

Near-term forecasts: Analysts are watching Boeing’s progress closely. Many note that Boeing still has to clear remaining certification hurdles and manage its supply chain. Aerospace strategist Tony Bancroft (Gabelli Funds) calls Boeing a “long-term winner,” noting its robust backlog and improving controls [27]. Bernstein’s Harned expects Boeing to meet its year-end production goals now that rework is done [28]. S&P global analyst Ben Tsocanos (cited in 2024) said new liquidity measures were “prudent” given Boeing’s credit needs. Overall, market-watchers see Boeing’s stock as having room to run if deliveries and cash flow keep improving – but the company’s own caution is clear. As Ortberg put it, Boeing will be patient adding rate “a month at a time” if needed, because losing stability would be worse [29].

What analysts say: In aggregate, experts believe Boeing’s turnaround story is intact but still fragile. Bernstein’s Douglas Harned notes that completing the MAX production rework is “a key performance indicator” for Boeing’s recovery [30]. Barclays analyst David Strauss called the FAA’s recent production news “surprising” in how strongly it boosted the stock [31]. Trading Block strategist Michael Martin highlights the recent U.S. defense funding boost, saying it “creates a favorable environment” with opportunities from government contracts [32]. On the cautionary side, aerospace analyst Glenn McDonald points out that supply-chain issues remain “more sporadic and unpredictable” than before the pandemic [33], meaning Boeing must navigate these challenges carefully.

Outlook: Boeing will report its Q3 2025 earnings on October 29, which should offer fresh data on deliveries and production plans. Investors will be looking for signs that Boeing can sustain higher output and return to consistent profitability. In the near term, analysts see a fair amount of bullish momentum (and room for further stock gains if forecasts are met) – but the company’s performance hinges on controlling costs and avoiding mishaps. If Boeing executes as expected, most experts feel the stock still has upside; if new disruptions arise, however, they warn BA could quickly give back gains [34] [35].

Sources: Stock data and analyst commentary are drawn from recent market reports [36] [37] and industry news [38] [39]. The article also incorporates expert quotes and targets from financial and aerospace publications [40] [41] [42] [43]. (All stock prices and performance figures are as of mid-Oct. 2025.)

FAA to ease restrictions on Boeing aircraft deliveries: Report

References

1. stockanalysis.com, 2. ts2.tech, 3. ts2.tech, 4. ts2.tech, 5. ts2.tech, 6. ts2.tech, 7. ts2.tech, 8. www.reuters.com, 9. www.reuters.com, 10. ts2.tech, 11. ts2.tech, 12. ts2.tech, 13. ts2.tech, 14. ts2.tech, 15. ts2.tech, 16. ts2.tech, 17. ts2.tech, 18. www.investing.com, 19. www.investing.com, 20. ts2.tech, 21. qz.com, 22. qz.com, 23. www.reuters.com, 24. ts2.tech, 25. www.reuters.com, 26. www.reuters.com, 27. qz.com, 28. www.investing.com, 29. www.reuters.com, 30. www.investing.com, 31. ts2.tech, 32. qz.com, 33. www.reuters.com, 34. www.reuters.com, 35. www.reuters.com, 36. stockanalysis.com, 37. ts2.tech, 38. www.reuters.com, 39. www.reuters.com, 40. www.reuters.com, 41. www.investing.com, 42. www.reuters.com, 43. qz.com

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Tariffs & Rare-Earth Gold Rush: Cleveland-Cliffs Stock Surges 19% on New Trade Policies
Previous Story

Tariffs & Rare-Earth Gold Rush: Cleveland-Cliffs Stock Surges 19% on New Trade Policies

APLD Stock Skyrockets on AI Data-Center Boom – What’s Driving the Rally?
Next Story

APLD Stock Skyrockets on AI Data-Center Boom – What’s Driving the Rally?

Stock Market Today

  • Inside Strava's $2.2B IPO: From Tracking App to Global Fitness Network
    October 20, 2025, 4:30 PM EDT. Strava's IPO story unfolds from a two-Harvard idea to a $2.2 billion market debut. The social and tracking network has surged from 40 million users in 2019 to about 150 million, driven by a successful freemium model that converts millions into subscribers and a fast-growing ARPU as users pay for premium features. The company's network effects-where more athletes generate more activity data and motivation-have boosted retention and organic growth, fueling a plan to reach roughly $500 million in annual recurring revenue. As Strava eyes public markets with banks like Goldman Sachs and JPMorgan in pitch roles, investors weigh the valuation, the long tail of data monetization, and the biggest risks and opportunities facing a fitness platform increasingly central to endurance sports globally.
  • AbbVie's RINVOQ Outperforms Humira in RA Head-to-Head; ABBV Stock Rises on Trial Readout
    October 20, 2025, 4:26 PM EDT. AbbVie reported positive topline data from the Phase 3b/4 SELECT-SWITCH trial, comparing upadacitinib 15 mg daily with adalimumab 40 mg biweekly in adults with moderate-to-severe rheumatoid arthritis inadequately controlled on a TNF inhibitor. At week 12, the primary endpoints were met, with RINVOQ outperforming HUMIRA: 43.3% vs 22.4% in low disease activity, and 28.4% vs 14.5% in remission (both stat. significant). No new safety risks were identified. ABBV stock traded around $230.82, up ~0.5% on the NYSE, underscoring investor focus on JAK1 inhibitor versus anti-TNF therapy and potential implications for the RA treatment landscape.
  • Yü Group appoints Andy Hughes as Chief Operating Officer
    October 20, 2025, 4:24 PM EDT. Yü Group PLC (YU.L) has appointed Andy Hughes as Chief Operating Officer. Hughes previously served as CEO of Water Plus and Director of Operations at Severn Trent. The company granted 170,000 share options under its Long-Term Incentive Plan, split into two tranches vesting in March 2028 and March 2029. YU.L closed at 1,604.28 GBP, down 35.72 GBP or 2.18% on the London Stock Exchange. This move aims to bolster executive leadership in the SME gas, electricity and smart meter supplier market.
  • CLP Holdings reports 1.8% drop in Hong Kong electricity sales; declares third interim dividend
    October 20, 2025, 4:22 PM EDT. CLP Holdings reported a 1.8% year-on-year drop in Hong Kong electricity sales to 27,456 GWh for the nine months ended 30 September 2025, amid milder weather. Manufacturing and residential demand fell 3.4% and 4%, while data center sales rose 6%. The company kept an unchanged third interim dividend of HK$0.63 per share, payable on 15 December 2025 to holders on record as of 4 December 2025. CLP continues investing in battery storage, smart metering, and renewable energy projects, with steady operations in mainland China, Australia, and India. The stock closed at HK$66.350, up 0.15% on the HKSE.
  • Fintech Optasia Launches IPO: What Investors Need to Know
    October 20, 2025, 4:20 PM EDT. Fintech Optasia has announced its IPO, prompting a closer look at the company's growth strategy and the fintech sector. The analysis covers the market debut, potential valuations, and how Optasia's technology and partnerships could influence its competitive position. Investors should consider fundraising needs, revenue mix, and regulatory risks as Optasia seeks capital to scale. The piece also places Optasia alongside other fintech IPOs, highlighting trends that could shape demand for the offering. As always, readers should weigh risks against potential upside in a sector characterized by rapid innovation and evolving compliance requirements. IPO, Optasia, fintech, investors, valuation, growth.
Go toTop